Pharmaceutical Online Videos
-
Regulatory Confidence, Manufacturing Excellence
10/20/2025
With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.
-
Argonaut Manufacturing Services Capacity Update October 2025: Fill/Finish
10/17/2025
Leverage advanced isolator-based fill-finish capabilities to achieve precise, efficient, and flexible sterile manufacturing for biologics, small molecules, vaccines, and other complex formulations from clinical through commercial scale.
-
Alcami Capacity Update October 2025: Fill/Finish
10/17/2025
Advance your injectable drug development with comprehensive formulation expertise that drives early-stage optimization, mitigates risk, and ensures seamless technical transfer for successful GMP clinical manufacturing.
-
Ropack Pharma Solutions Capacity Update October 2025: Small Molecule
10/16/2025
For clinical trials, we provide full support from warehousing to returns. Join Ropack's Head of Commercial, Chris Vounasis, for a presentation on our technologies and 2025–2026 capacity.
-
Pfizer CentreOne Oral Solids Capacity Update October 2025: Small Molecule
10/16/2025
With specialized technologies like laser drilling, multilayer coating, and orally disintegrating tablets, our state-of-the-art facilities provide the precise infrastructure to support your most demanding OSD requirements.
-
Lonza Capacity Update October 2025: Small Molecule
10/16/2025
Get an overview of our AI-assisted early phase toolkit, which combines predictive modeling, formulation screening, and data-driven insights to accelerate molecule progression.
-
Douglas CDMO Capacity Update October 2025: Small Molecule
10/16/2025
Choose an experienced CDMO specializing in high-potency softgels and liquids to ensure high-quality products, responsive service, and reliable solutions across complex therapeutic areas.
-
Alcami Capacity Update October 2025: Small Molecule
10/16/2025
Partner with a flexible, high-quality manufacturing expert to accelerate your bench-to-clinic journey, strengthen supply chain, and ensure seamless commercialization of oral solid dose therapies.
-
Nanoform Capacity Update October 2025: Large Molecule
10/16/2025
Sergie Letser, Deputy CCO, presents an overview of Nanoform’s novel large molecule nanoforming technology capabilities and current capacity.
-
Biosimilar Development: Early-Stage Characterization To QC Release
10/15/2025
SGS provides a complete range of bioanalytical solutions, including method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, immunogenicity testing.